» Articles » PMID: 35857588

TCR-Vγδ Usage Distinguishes Protumor from Antitumor Intestinal γδ T Cell Subsets

Abstract

γδ T cells represent a substantial fraction of intestinal lymphocytes at homeostasis, but they also constitute a major lymphocyte population infiltrating colorectal cancers (CRCs); however, their temporal contribution to CRC development or progression remains unclear. Using human CRC samples and murine CRC models, we found that most γδ T cells in premalignant or nontumor colons exhibit cytotoxic markers, whereas tumor-infiltrating γδ T cells express a protumorigenic profile. These contrasting T cell profiles were associated with distinct T cell receptor (TCR)-Vγδ gene usage in both humans and mice. Longitudinal intersectional genetics and antibody-dependent strategies targeting murine γδ T cells enriched in the epithelium at steady state led to heightened tumor development, whereas targeting γδ subsets that accumulate during CRC resulted in reduced tumor growth. Our results uncover temporal pro- and antitumor roles for γδ T cell subsets.

Citing Articles

Ligands for Intestinal Intraepithelial T Lymphocytes in Health and Disease.

Hada A, Xiao Z Pathogens. 2025; 14(2).

PMID: 40005486 PMC: 11858322. DOI: 10.3390/pathogens14020109.


Integrating of Radiomics and Single-cell Transcriptomics Uncovers the Crucial Role of γδ T Cells in Lung Adenocarcinoma.

Chen Z, Yang C, Wang J, Wang B, He L, Liu Z J Cancer. 2025; 16(4):1167-1180.

PMID: 39895781 PMC: 11786044. DOI: 10.7150/jca.105586.


The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies.

Wang Q, Yu M, Zhang S Front Immunol. 2025; 15:1440830.

PMID: 39877377 PMC: 11772360. DOI: 10.3389/fimmu.2024.1440830.


Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments.

Luo X, Lv Y, Yang J, Long R, Qiu J, Deng Y Front Med (Lausanne). 2025; 11:1480191.

PMID: 39748921 PMC: 11693687. DOI: 10.3389/fmed.2024.1480191.


Tumor-Infiltrating Immune Cells in Colorectal Cancer.

Ferkel S, Holman E, Sojwal R, Rubin S, Rogalla S Neoplasia. 2024; 59:101091.

PMID: 39642846 PMC: 11665540. DOI: 10.1016/j.neo.2024.101091.


References
1.
Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S . Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut. 1996; 39(1):87-92. PMC: 1383238. DOI: 10.1136/gut.39.1.87. View

2.
Dmitrieva-Posocco O, Dzutsev A, Posocco D, Hou V, Yuan W, Thovarai V . Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer. Immunity. 2019; 50(1):166-180.e7. PMC: 6490968. DOI: 10.1016/j.immuni.2018.11.015. View

3.
Sujino T, London M, Hoytema van Konijnenburg D, Rendon T, Buch T, Silva H . Tissue adaptation of regulatory and intraepithelial CD4⁺ T cells controls gut inflammation. Science. 2016; 352(6293):1581-6. PMC: 4968079. DOI: 10.1126/science.aaf3892. View

4.
Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O . Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016; 167(1):203-218.e17. PMC: 5037318. DOI: 10.1016/j.cell.2016.08.030. View

5.
Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B . Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019; 176(5):998-1013.e16. PMC: 6691977. DOI: 10.1016/j.cell.2018.12.040. View